125 related articles for article (PubMed ID: 22903508)
1. Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis.
Okazaki K; Yamaguchi T; Tanaka K; Notsu M; Ogawa N; Yano S; Sugimoto T
Calcif Tissue Int; 2012 Oct; 91(4):286-96. PubMed ID: 22903508
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products suppress osteoblastic differentiation of stromal cells by activating endoplasmic reticulum stress.
Tanaka K; Yamaguchi T; Kaji H; Kanazawa I; Sugimoto T
Biochem Biophys Res Commun; 2013 Aug; 438(3):463-7. PubMed ID: 23933252
[TBL] [Abstract][Full Text] [Related]
3. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs.
Ogawa N; Yamaguchi T; Yano S; Yamauchi M; Yamamoto M; Sugimoto T
Horm Metab Res; 2007 Dec; 39(12):871-5. PubMed ID: 17960513
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end product 3 (AGE3) suppresses the mineralization of mouse stromal ST2 cells and human mesenchymal stem cells by increasing TGF-β expression and secretion.
Notsu M; Yamaguchi T; Okazaki K; Tanaka K; Ogawa N; Kanazawa I; Sugimoto T
Endocrinology; 2014 Jul; 155(7):2402-10. PubMed ID: 24758301
[TBL] [Abstract][Full Text] [Related]
5. Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells.
Tanaka K; Yamaguchi T; Kanazawa I; Sugimoto T
Biochem Biophys Res Commun; 2015 May; 461(2):193-9. PubMed ID: 25721666
[TBL] [Abstract][Full Text] [Related]
6. Insulin-Like Growth Factor-I Protects Against the Detrimental Effects of Advanced Glycation End Products and High Glucose in Myoblastic C2C12 Cells.
Adachi N; Kanazawa I; Tanaka KI; Takeno A; Notsu M; Tanaka S; Sugimoto T
Calcif Tissue Int; 2019 Jul; 105(1):89-96. PubMed ID: 30809689
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.
Kume S; Kato S; Yamagishi S; Inagaki Y; Ueda S; Arima N; Okawa T; Kojiro M; Nagata K
J Bone Miner Res; 2005 Sep; 20(9):1647-58. PubMed ID: 16059636
[TBL] [Abstract][Full Text] [Related]
8. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus.
Lim M; Park L; Shin G; Hong H; Kang I; Park Y
Ann N Y Acad Sci; 2008 Dec; 1150():311-5. PubMed ID: 19120318
[TBL] [Abstract][Full Text] [Related]
10. Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation.
Fernández JM; Molinuevo MS; Sedlinsky C; Schurman L; Cortizo AM; McCarthy AD
Eur J Pharmacol; 2013 Apr; 706(1-3):41-7. PubMed ID: 23499695
[TBL] [Abstract][Full Text] [Related]
11. Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells.
Notsu M; Kanazawa I; Takeno A; Yokomoto-Umakoshi M; Tanaka KI; Yamaguchi T; Sugimoto T
Calcif Tissue Int; 2017 Apr; 100(4):402-411. PubMed ID: 28229177
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products-induced vascular calcification is mediated by oxidative stress: functional roles of NAD(P)H-oxidase.
Tada Y; Yano S; Yamaguchi T; Okazaki K; Ogawa N; Morita M; Sugimoto T
Horm Metab Res; 2013 Apr; 45(4):267-72. PubMed ID: 23225244
[TBL] [Abstract][Full Text] [Related]
13. Active vitamin D possesses beneficial effects on the interaction between muscle and bone.
Tanaka K; Kanazawa I; Yamaguchi T; Yano S; Kaji H; Sugimoto T
Biochem Biophys Res Commun; 2014 Jul; 450(1):482-7. PubMed ID: 24924628
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-2 induces the differentiation of a mesenchymal progenitor cell line, ROB-C26, into mature osteoblasts and adipocytes.
Kato S; Kawabata N; Suzuki N; Ohmura M; Takagi M
Life Sci; 2009 Feb; 84(9-10):302-10. PubMed ID: 19146860
[TBL] [Abstract][Full Text] [Related]
15. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
[TBL] [Abstract][Full Text] [Related]
16. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone.
Huang L; Teng XY; Cheng YY; Lee KM; Kumta SM
Bone; 2004 Mar; 34(3):393-401. PubMed ID: 15003787
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
Fromigué O; Marie PJ; Lomri A
J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
[TBL] [Abstract][Full Text] [Related]
18. Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway.
Uemura T; Ohta Y; Nakao Y; Manaka T; Nakamura H; Takaoka K
Bone; 2010 Oct; 47(4):756-65. PubMed ID: 20637325
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end-product 2 and Porphyromonas gingivalis lipopolysaccharide increase sclerostin expression in mouse osteocyte-like cells.
Sakamoto E; Kido JI; Takagi R; Inagaki Y; Naruishi K; Nagata T; Yumoto H
Bone; 2019 May; 122():22-30. PubMed ID: 30735798
[TBL] [Abstract][Full Text] [Related]
20. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor.
Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R
Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
